OLIPASS CORPORATION
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
244460 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 동백중앙로16번길 16-4 에이스동백타워1동 20층, 용인시
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
OLIPASS CORPORATION is a biotechnology company focused on the research and development of RNA therapeutics. The company's core technology is its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. This platform utilizes a modified PNA with covalently attached cationic lipid groups, which significantly enhances cell permeability. OPNA is designed to induce exon skipping by specifically binding to target pre-mRNA within the cell nucleus. This mechanism enables the development of a pipeline of novel therapeutic drug candidates for various diseases. The company's vision is to become a leading global R&D company in the field of RNA therapeutics.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for OLIPASS CORPORATION and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all OLIPASS CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for OLIPASS CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
